SCHEMBL4931357

SCHEMBL4931357

CCCNc1cccc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.48
THRB P10828 1/20 0.48
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
PDE5A O76074 1/20 0.44
MRGPRX4 Q96LA9 7/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ABL1 P00519 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
RIN1 Q13671 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PLAU P00749 1/20 0.41
SENP5 Q96HI0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5718124 0.95 THRB (0.44) THRATHRBRAB9ANPC1MEN1
SCHEMBL4347509 0.92 THRA (0.57) THRATHRBRAB9ANPC1MEN1
SCHEMBL4356831 0.90 THRA (0.58) THRATHRBRAB9ANPC1MEN1
SCHEMBL4932637 0.88 HSD17B10 (0.40) RAB9ANPC1MEN1KMT2APDE5A
SCHEMBL4932507 0.87 RAB9A (0.47) THRATHRBRAB9ANPC1MEN1
SCHEMBL5718130 0.87 MRGPRX4 (0.41) THRATHRBRAB9ANPC1MEN1
SCHEMBL4932166 0.87 HSD17B10 (0.39) RAB9ANPC1MEN1KMT2APDE5A
SCHEMBL4932449 0.87 HSD17B10 (0.39) RAB9ANPC1MEN1KMT2APDE5A
SCHEMBL5112743 0.86 SENP1 (0.52) THRATHRBRAB9ANPC1MEN1
SCHEMBL5119979 0.85 MEN1 (0.50) RAB9ANPC1MEN1KMT2APDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRA 3/4885THRB 4/4885RAB9A 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.